Pfizer breast cancer drug gets early FDA approval
Federal health regulators on Tuesday approved a highly anticipated medicine from Pfizer Inc. to treat postmenopausal women with a certain type of advanced breast cancer who have not already taken other drugs.
Feb 3, 2015
1
3